Danaher - 1792 Exchange

Corporate Bias Rating

Expand Summary

Risk Level:

High Risk

Summary:

Danaher often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes Danaher occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.

View Full Corporate Bias Ratings Report

Board Bias

Expand Summary

CEO of Danaher

Rainer M. Blair

Summary:

Headquartered in Washington, D.C., Washington D.C., Danaher is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Rainer M. Blair and Mitchell P. Rales, Steven M. Rales serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $4,600 to Republican causes and $84,550 to Democratic causes. Under their tenure, Danaher currently holds a 'High Risk' risk rating.

View Full Board Bias Report

Political Contributions of Leadership:

$4,600

$84,550

Republican

Democrat

Shareholder Proposals

Expand Summary

Date	ESG Category	Proponent	Summary of Resolution	Mgmt Rec	Total Vote % in Favor
5/7/24	Governance	John Chevedden	Special Shareholder Meeting Improvement	Against	43.11%
5/7/24	Social	As You Sow	Report on Company's Diversity, Equity, and Inclusion Efforts	Against	13.96%
5/9/23	Governance	John Chevedden	Require Two Seperate People Hold the Offices of Chairman and CEO	Against	38.30%
5/9/23	Environmental	As You Sow	Greater Disclosure of Material Corporate Diversity	Against	16.10%
5/10/22	Governance	N/A - Undisclosed	Special Meetings - Reduce Ownership Req. to 10%	Against	43.13%